Skip to main content
Caplight Logo









Lovaltech

Lovaltech

Private
ToursHealthcare & Life Scienceshttps://www.lovaltechnology.com/

Last Round

Seed

Apr 23, 2024

Total Funding Raised

$8.07M

Company Overview

Lovaltech is a biotechnology company that develops protein-based nasal vaccines designed to induce mucosal and systemic immunity to prevent infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

intranasal vaccinemucosal immunityprotein subunit vaccineneedle-free vaccinemuco-adhesive excipientrespiratory pathogenthermostable vaccinebiotechnologyvaccine deliverypreclinical developmentgood manufacturing practiceGMPregulatory toxicologynext-gen vaccinemucosal vaccine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lovaltech Comparables

Compare Lovaltech with similar companies based on industry and business-model similarity.

Lovaltech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vaxinano
83%
CastleVax Inc.
81%
Codagenix
78%

Lovaltech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 23, 2024
GrantApr 23, 2024
Pre SeedJun 1, 2023

Lovaltech Investors

Notable investors and investment history

Lovaltech investors
InvestorRounds
Da Vinci LabsSeed, Pre Seed
BpifranceGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors increased 199% MoM, reaching 933.

  • Feb 20, 2026

    Grew 75% QoQ, from 4 to 7 employees.

Lovaltech Filings

Explore SEC and related filing metadata, where available.

Lovaltech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lovaltech's valuation, stock price, and market status.

Is Lovaltech a public or private company?

Lovaltech is a private company.

What is the current stock price of Lovaltech?

Lovaltech is a private company with no public stock price. No recent secondary market data is available.

How much is Lovaltech worth (valuation)?

Valuation information for Lovaltech is not publicly available.

Can I buy Lovaltech stock?

Lovaltech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lovaltech's last funding round?

Lovaltech's most recent funding round was Seed on April 23, 2024.

Who are the main investors in Lovaltech?

Key investors in Lovaltech include Da Vinci Labs.

Will Lovaltech IPO soon?

No public IPO plans have been announced for Lovaltech.

How can I track Lovaltech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lovaltech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTours
Employee Range4
Year Founded2022
Last FundingApr 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?